R&D
R&D
R&D Platform
R&D
R&D Platform
R&D Platform
Development of New Antibody Drugs
Novel therapeutic antibodies against PX protein for the treatment of inflammation and fibrosis
Development of New Synthetic Drugs for Nox Inhibitors
Screening Nox Inhibitors Using Human Nox Gene Modified Fruit Flies
Address : CELROS BIOTECH strives to extend life and improve quality of life by developing antibodies targeting inflammatory diseases and new synthetic drugs to inhibit Nox. Tel : 070-4651-4380~1 Fax : 070-8230-4382 E-mail : foever23@celros.com, chn6307@celros.com